To improve access to Symbicort (asthma drug) in India
AstraZeneca Pharma India and Mankind Pharma entered into an agreement for exclusive distribution of AstraZeneca's budesonide and formoterol fumarate dihydrate (inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA) combination) brand Symbicort in India. AstraZeneca will retain the intellectual property rights to budesonide and formoterol fumarate dihydrate and will continue to be the Marketing Authorisation Holder (MAH) and import license.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content